Howard S. Boswell, MD
Professor of Medicine
- Address
-
Joseph E. Walther Hall, Room C321A
980 W. Walnut St.
Indianapolis , IN 46202 - PubMed:
-
| Year | Degree | Institution |
|---|---|---|
| 1982 | Residency | University of Virginia, Charlottesville, VA |
| 1977 | MD | University of Virginia |
| 1973 | BS | Hampden-Sydney College |
Oncogene signal transduction in leukemias
Genotoxic stresses promote clonal expansion of hematopoietic stem cells expressing mutant p53.
Chen S; Gao R; Yao C; Kobayashi M; Liu SZ; Yoder MC; Broxmeyer H; Kapur R; Boswell HS; Mayo LD; Liu Y; Leukemia 2017 Nov 16
Chen S; Gao R; Yao C; Kobayashi M; Liu SZ; Yoder MC; Broxmeyer H; Kapur R; Boswell HS; Mayo LD; Liu Y; Leukemia 2017 Nov 16
DPP4 truncated GM-CSF and IL-3 manifest distinct receptor-binding and regulatory functions compared with their full-length forms.
O'Leary HA; Capitano M; Cooper S; Mantel C; Boswell HS; Kapur R; Ramdas B; Chan R; Deng L; Qu CK; Broxmeyer HE; Leukemia 2017 Mar 27
O'Leary HA; Capitano M; Cooper S; Mantel C; Boswell HS; Kapur R; Ramdas B; Chan R; Deng L; Qu CK; Broxmeyer HE; Leukemia 2017 Mar 27
Phosphatase PRL2 promotes AML1-ETO-induced acute myeloid leukemia.
Kobayashi M; Chen S; Bai Y; Yao C; Gao R; Sun XJ; Mu C; Twiggs TA; Yu ZH; Boswell HS; Yoder MC; Kapur R; Mulloy JC; Zhang ZY; Liu Y; Leukemia 2017 Feb 21
Kobayashi M; Chen S; Bai Y; Yao C; Gao R; Sun XJ; Mu C; Twiggs TA; Yu ZH; Boswell HS; Yoder MC; Kapur R; Mulloy JC; Zhang ZY; Liu Y; Leukemia 2017 Feb 21
Consecutive epigenetically-active agent combinations act in <i>ID1-RUNX3-TET2</i> and <i>HOXA</i> pathways for <i>Flt3ITD+ve</i> AML.
Sayar H; Liu Y; Gao R; Zaid MA; Cripe LD; Weisenbach J; Sargent KJ; Nassiri M; Li L; Konig H; Suvannasankha A; Pan F; Shanmugam R; Goswami C; Kapur R; Xu M; Boswell HS; Oncotarget 2017 Dec 25
Sayar H; Liu Y; Gao R; Zaid MA; Cripe LD; Weisenbach J; Sargent KJ; Nassiri M; Li L; Konig H; Suvannasankha A; Pan F; Shanmugam R; Goswami C; Kapur R; Xu M; Boswell HS; Oncotarget 2017 Dec 25
Death-associated Protein Kinase-1 Expression and Autophagy in Chronic Lymphocytic Leukemia Are Dependent on Activating Transcription Factor-6 and CCAAT/Enhancer-binding Protein-ß.
Gade P; Kimball AS; DiNardo AC; Gangwal P; Ross DD; Boswell HS; Keay SK; Kalvakolanu DV; The Journal of biological chemistry 2016 Sep 2
Gade P; Kimball AS; DiNardo AC; Gangwal P; Ross DD; Boswell HS; Keay SK; Kalvakolanu DV; The Journal of biological chemistry 2016 Sep 2
Syk kinase and Shp2 phosphatase inhibition cooperate to reduce FLT3-ITD-induced STAT5 activation and proliferation of acute myeloid leukemia.
Richine BM; Virts EL; Bowling JD; Ramdas B; Mali R; Naoye R; Liu Z; Zhang ZY; Boswell HS; Kapur R; Chan RJ; Leukemia 2016 May 20
Richine BM; Virts EL; Bowling JD; Ramdas B; Mali R; Naoye R; Liu Z; Zhang ZY; Boswell HS; Kapur R; Chan RJ; Leukemia 2016 May 20
Regulation of Stat5 by FAK and PAK1 in Oncogenic FLT3- and KIT-Driven Leukemogenesis.
Chatterjee A; Ghosh J; Ramdas B; Mali RS; Martin H; Kobayashi M; Vemula S; Canela VH; Waskow ER; Visconte V; Tiu RV; Smith CC; Shah N; Bunting KD; Boswell HS; Liu Y; Chan RJ; Kapur R; Cell reports 2014 Nov 13
Chatterjee A; Ghosh J; Ramdas B; Mali RS; Martin H; Kobayashi M; Vemula S; Canela VH; Waskow ER; Visconte V; Tiu RV; Smith CC; Shah N; Bunting KD; Boswell HS; Liu Y; Chan RJ; Kapur R; Cell reports 2014 Nov 13
Notch-dependent repression of miR-155 in the bone marrow niche regulates hematopoiesis in an NF-?B-dependent manner.
Wang L; Zhang H; Rodriguez S; Cao L; Parish J; Mumaw C; Zollman A; Kamoka MM; Mu J; Chen DZ; Srour EF; Chitteti BR; HogenEsch H; Tu X; Bellido TM; Boswell HS; Manshouri T; Verstovsek S; Yoder MC; Kapur R; Cardoso AA; Carlesso N; Cell stem cell 2014 Jul 3
Wang L; Zhang H; Rodriguez S; Cao L; Parish J; Mumaw C; Zollman A; Kamoka MM; Mu J; Chen DZ; Srour EF; Chitteti BR; HogenEsch H; Tu X; Bellido TM; Boswell HS; Manshouri T; Verstovsek S; Yoder MC; Kapur R; Cardoso AA; Carlesso N; Cell stem cell 2014 Jul 3
The protein tyrosine phosphatase, Shp2, positively contributes to FLT3-ITD-induced hematopoietic progenitor hyperproliferation and malignant disease in vivo.
Nabinger SC; Li XJ; Ramdas B; He Y; Zhang X; Zeng L; Richine B; Bowling JD; Fukuda S; Goenka S; Liu Z; Feng GS; Yu M; Sandusky GE; Boswell HS; Zhang ZY; Kapur R; Chan RJ; Leukemia 2012 Oct 22
Nabinger SC; Li XJ; Ramdas B; He Y; Zhang X; Zeng L; Richine B; Bowling JD; Fukuda S; Goenka S; Liu Z; Feng GS; Yu M; Sandusky GE; Boswell HS; Zhang ZY; Kapur R; Chan RJ; Leukemia 2012 Oct 22
Rho kinase regulates the survival and transformation of cells bearing oncogenic forms of KIT, FLT3, and BCR-ABL.
Mali RS; Ramdas B; Ma P; Shi J; Munugalavadla V; Sims E; Wei L; Vemula S; Nabinger SC; Goodwin CB; Chan RJ; Traina F; Visconte V; Tiu RV; Lewis TA; Stern AM; Wen Q; Crispino JD; Boswell HS; Kapur R; Cancer cell 2011 Sep 13
Mali RS; Ramdas B; Ma P; Shi J; Munugalavadla V; Sims E; Wei L; Vemula S; Nabinger SC; Goodwin CB; Chan RJ; Traina F; Visconte V; Tiu RV; Lewis TA; Stern AM; Wen Q; Crispino JD; Boswell HS; Kapur R; Cancer cell 2011 Sep 13
A noncanonical Flt3ITD/NF-?B signaling pathway represses DAPK1 in acute myeloid leukemia.
Shanmugam R; Gade P; Wilson-Weekes A; Sayar H; Suvannasankha A; Goswami C; Li L; Gupta S; Cardoso AA; Al Baghdadi T; Sargent KJ; Cripe LD; Kalvakolanu DV; Boswell HS; Clinical cancer research : an official journal of the American Association for Cancer Research 2011 Nov 17
Shanmugam R; Gade P; Wilson-Weekes A; Sayar H; Suvannasankha A; Goswami C; Li L; Gupta S; Cardoso AA; Al Baghdadi T; Sargent KJ; Cripe LD; Kalvakolanu DV; Boswell HS; Clinical cancer research : an official journal of the American Association for Cancer Research 2011 Nov 17
Novel combination treatments targeting chronic myeloid leukemia stem cells.
Al Baghdadi T; Abonour R; Boswell HS; Clinical lymphoma, myeloma & leukemia 2011 Dec 16
Al Baghdadi T; Abonour R; Boswell HS; Clinical lymphoma, myeloma & leukemia 2011 Dec 16
Survivin mediates aberrant hematopoietic progenitor cell proliferation and acute leukemia in mice induced by internal tandem duplication of Flt3.
Fukuda S; Singh P; Moh A; Abe M; Conway EM; Boswell HS; Yamaguchi S; Fu XY; Pelus LM; Blood 2009 May 1
Fukuda S; Singh P; Moh A; Abe M; Conway EM; Boswell HS; Yamaguchi S; Fu XY; Pelus LM; Blood 2009 May 1
Antimyeloma effects of a sesquiterpene lactone parthenolide.
Suvannasankha A; Crean CD; Shanmugam R; Farag SS; Abonour R; Boswell HS; Nakshatri H; Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Mar 15
Suvannasankha A; Crean CD; Shanmugam R; Farag SS; Abonour R; Boswell HS; Nakshatri H; Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Mar 15
Source separation of household waste: a case study in China.
Zhuang Y; Wu SW; Wang YL; Wu WX; Chen YX; Waste management (New York, N.Y.) 2007 Oct 24
Zhuang Y; Wu SW; Wang YL; Wu WX; Chen YX; Waste management (New York, N.Y.) 2007 Oct 24
Role for c-jun N-terminal kinase in treatment-refractory acute myeloid leukemia (AML): signaling to multidrug-efflux and hyperproliferation.
Cripe LD; Gelfanov VM; Smith EA; Spigel DR; Phillips CA; Gabig TG; Jung SH; Fyffe J; Hartman AD; Kneebone P; Mercola D; Burgess GS; Boswell HS; Leukemia 2002 May
Cripe LD; Gelfanov VM; Smith EA; Spigel DR; Phillips CA; Gabig TG; Jung SH; Fyffe J; Hartman AD; Kneebone P; Mercola D; Burgess GS; Boswell HS; Leukemia 2002 May
Transformation of interleukin-3-dependent cells without participation of Stat5/bcl-xL: cooperation of akt with raf/erk leads to p65 nuclear factor kappaB-mediated antiapoptosis involving c-IAP2.
Gelfanov VM; Burgess GS; Litz-Jackson S; King AJ; Marshall MS; Nakshatri H; Boswell HS; Blood 2001 Oct 15
Gelfanov VM; Burgess GS; Litz-Jackson S; King AJ; Marshall MS; Nakshatri H; Boswell HS; Blood 2001 Oct 15
Induction of apoptosis by arachidonic acid in chronic myeloid leukemia cells.
Rizzo MT; Regazzi E; Garau D; Akard L; Dugan M; Boswell HS; Rizzoli V; Carlo-Stella C; Cancer research 1999 Oct 1
Rizzo MT; Regazzi E; Garau D; Akard L; Dugan M; Boswell HS; Rizzoli V; Carlo-Stella C; Cancer research 1999 Oct 1
Regulation of the c-jun gene in p210 BCR-ABL transformed cells corresponds with activity of JNK, the c-jun N-terminal kinase.
Burgess GS; Williamson EA; Cripe LD; Litz-Jackson S; Bhatt JA; Stanley K; Stewart MJ; Kraft AS; Nakshatri H; Boswell HS; Blood 1998 Oct 1
Burgess GS; Williamson EA; Cripe LD; Litz-Jackson S; Bhatt JA; Stanley K; Stewart MJ; Kraft AS; Nakshatri H; Boswell HS; Blood 1998 Oct 1
Cyclic AMP negatively controls c-myc transcription and G1 cell cycle progression in p210 BCR-ABL transformed cells: inhibitory activity exerted through cyclin D1 and cdk4.
Williamson EA; Burgess GS; Eder P; Litz-Jackson S; Boswell HS; Leukemia 1997 Jan
Williamson EA; Burgess GS; Eder P; Litz-Jackson S; Boswell HS; Leukemia 1997 Jan
Steel factor induces serine phosphorylation of Stat3 in human growth factor-dependent myeloid cell lines.
Gotoh A; Takahira H; Mantel C; Litz-Jackson S; Boswell HS; Broxmeyer HE; Blood 1996 Jul 1
Gotoh A; Takahira H; Mantel C; Litz-Jackson S; Boswell HS; Broxmeyer HE; Blood 1996 Jul 1
Role for E2F1 in p210 BCR-ABL downstream regulation of c-myc transcription initiation. Studies in murine myeloid cells.
Stewart MJ; Litz-Jackson S; Burgess GS; Williamson EA; Leibowitz DS; Boswell HS; Leukemia 1995 Sep
Stewart MJ; Litz-Jackson S; Burgess GS; Williamson EA; Leibowitz DS; Boswell HS; Leukemia 1995 Sep
Arachidonic acid induces c-jun gene expression in stromal cells stimulated by interleukin-1 and tumor necrosis factor-alpha: evidence for a tyrosine-kinase-dependent process.
Rizzo MT; Boswell HS; Mangoni L; Carlo-Stella C; Rizzoli V; Blood 1995 Oct 15
Rizzo MT; Boswell HS; Mangoni L; Carlo-Stella C; Rizzoli V; Blood 1995 Oct 15
Tyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) by BCR-ABL oncoprotein.
Gotoh A; Miyazawa K; Ohyashiki K; Tauchi T; Boswell HS; Broxmeyer HE; Toyama K; Experimental hematology 1995 Oct
Gotoh A; Miyazawa K; Ohyashiki K; Tauchi T; Boswell HS; Broxmeyer HE; Toyama K; Experimental hematology 1995 Oct
Adeno-associated virus 2-mediated gene transfer and functional expression of the human granulocyte-macrophage colony-stimulating factor.
Luo F; Zhou SZ; Cooper S; Munshi NC; Boswell HS; Broxmeyer HE; Srivastava A; Experimental hematology 1995 Nov
Luo F; Zhou SZ; Cooper S; Munshi NC; Boswell HS; Broxmeyer HE; Srivastava A; Experimental hematology 1995 Nov
Signal transduction during myeloid cell differentiation.
Williamson EA; Boswell HS; Current opinion in hematology 1995 Jan
Williamson EA; Boswell HS; Current opinion in hematology 1995 Jan
AP-1/C-jun and C-myc Regulation During Megakaryocytic Differentiation of a Human Bi-potential Growth-factor-dependent Cell Line.
Derigs HG; Morgan DA; Hoffman R; Litz SL; Srour EF; Brandt JE; Boswell HS; Platelets 1995
Derigs HG; Morgan DA; Hoffman R; Litz SL; Srour EF; Brandt JE; Boswell HS; Platelets 1995
Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway.
Tauchi T; Boswell HS; Leibowitz D; Broxmeyer HE; The Journal of experimental medicine 1994 Jan 1
Tauchi T; Boswell HS; Leibowitz D; Broxmeyer HE; The Journal of experimental medicine 1994 Jan 1
Regulation of interleukin-1 and tumor necrosis factor-alpha induced granulocyte-macrophage colony-stimulating factor gene expression: potential involvement of arachidonic acid metabolism.
Rizzo MT; Boswell HS; Experimental hematology 1994 Jan
Rizzo MT; Boswell HS; Experimental hematology 1994 Jan
Granulocyte-macrophage colony-stimulating factor expression is regulated at transcriptional and posttranscriptional levels in a murine bone marrow stromal cell line.
Derigs HG; Reifel-Miller A; Kaushansky K; Hromas RA; Boswell HS; Experimental hematology 1994 Aug
Derigs HG; Reifel-Miller A; Kaushansky K; Hromas RA; Boswell HS; Experimental hematology 1994 Aug
p210 bcr-abl confers overexpression of inosine monophosphate dehydrogenase: an intrinsic pathway to drug resistance mediated by oncogene.
Gharehbaghi K; Burgess GS; Collart FR; Litz-Jackson S; Huberman E; Jayaram HN; Boswell HS; Leukemia 1994 Aug
Gharehbaghi K; Burgess GS; Collart FR; Litz-Jackson S; Huberman E; Jayaram HN; Boswell HS; Leukemia 1994 Aug
Role of p21 RAS in p210 bcr-abl transformation of murine myeloid cells.
Mandanas RA; Leibowitz DS; Gharehbaghi K; Tauchi T; Burgess GS; Miyazawa K; Jayaram HN; Boswell HS; Blood 1993 Sep 15
Mandanas RA; Leibowitz DS; Gharehbaghi K; Tauchi T; Burgess GS; Miyazawa K; Jayaram HN; Boswell HS; Blood 1993 Sep 15
Stimulation of interleukin-6 production by either calcitonin gene-related peptide or parathyroid hormone in two phenotypically distinct bone marrow-derived murine stromal cell lines.
Sakagami Y; Girasole G; Yu XP; Boswell HS; Manolagas SC; Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1993 Jul
Sakagami Y; Girasole G; Yu XP; Boswell HS; Manolagas SC; Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1993 Jul
LIF mRNA expression is transcriptionally regulated in murine bone marrow stromal cells.
Derigs HG; Boswell HS; Leukemia 1993 Apr
Derigs HG; Boswell HS; Leukemia 1993 Apr
Oncogene intervention into hematopoietic signaling.
Boswell HS; The Journal of laboratory and clinical medicine 1992 Nov
Boswell HS; The Journal of laboratory and clinical medicine 1992 Nov
Dissociation of nuclear events on p21 RAS transformation of FDC-P1 myeloid cells: c-jun/AP-1 expression versus c-myc transcription.
Litz-Jackson S; Miller AH; Burgess GS; Boswell HS; Blood 1992 May 1
Litz-Jackson S; Miller AH; Burgess GS; Boswell HS; Blood 1992 May 1
BCR/ABL confers growth factor independence upon a murine myeloid cell line.
Mandanas RA; Boswell HS; Lu L; Leibowitz D; Leukemia 1992 Aug
Mandanas RA; Boswell HS; Lu L; Leibowitz D; Leukemia 1992 Aug
Interleukin-3 dependent mitogenesis in murine cells involves a predominant non-protein kinase C (pKC) dependent pathway for c-myc transcription. Role of a myc expression vector in rescuing pKC dependent mitogenesis.
Nahreini TS; Litz-Jackson S; Burgess GS; Helvering LM; Manolagas SC; Boswell HS; Leukemia 1991 Dec
Nahreini TS; Litz-Jackson S; Burgess GS; Helvering LM; Manolagas SC; Boswell HS; Leukemia 1991 Dec
Requirement for mast cell growth factor for primordial germ cell survival in culture.
Dolci S; Williams DE; Ernst MK; Resnick JL; Brannan CI; Lock LF; Lyman SD; Boswell HS; Donovan PJ; Nature 1991 Aug 29
Dolci S; Williams DE; Ernst MK; Resnick JL; Brannan CI; Lock LF; Lyman SD; Boswell HS; Donovan PJ; Nature 1991 Aug 29
Expression of val-12 mutant ras p21 in an IL-3-dependent murine myeloid cell line is associated with loss of serum-dependence and increases in membrane PIP2-specific phospholipase C activity.
Rizzo MT; Boswell HS; English D; Gabig TG; Cellular signalling 1991
Rizzo MT; Boswell HS; English D; Gabig TG; Cellular signalling 1991
T-cell growth factor P40 promotes the proliferation of myeloid cell lines and enhances erythroid burst formation by normal murine bone marrow cells in vitro.
Williams DE; Morrissey PJ; Mochizuki DY; de Vries P; Anderson D; Cosman D; Boswell HS; Cooper S; Grabstein KH; Broxmeyer HE; Blood 1990 Sep 1
Williams DE; Morrissey PJ; Mochizuki DY; de Vries P; Anderson D; Cosman D; Boswell HS; Cooper S; Grabstein KH; Broxmeyer HE; Blood 1990 Sep 1
Identification of a ligand for the c-kit proto-oncogene.
Williams DE; Eisenman J; Baird A; Rauch C; Van Ness K; March CJ; Park LS; Martin U; Mochizuki DY; Boswell HS; Cell 1990 Oct 5
Williams DE; Eisenman J; Baird A; Rauch C; Van Ness K; March CJ; Park LS; Martin U; Mochizuki DY; Boswell HS; Cell 1990 Oct 5
Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms.
Anderson DM; Lyman SD; Baird A; Wignall JM; Eisenman J; Rauch C; March CJ; Boswell HS; Gimpel SD; Cosman D; Cell 1990 Oct 5
Anderson DM; Lyman SD; Baird A; Wignall JM; Eisenman J; Rauch C; March CJ; Boswell HS; Gimpel SD; Cosman D; Cell 1990 Oct 5
A RAS oncogene imparts growth factor independence to myeloid cells that abnormally regulate protein kinase C: a nonautocrine transformation pathway.
Boswell HS; Nahreini TS; Burgess GS; Srivastava A; Gabig TG; Inhorn L; Srour EF; Harrington MA; Experimental hematology 1990 Jun
Boswell HS; Nahreini TS; Burgess GS; Srivastava A; Gabig TG; Inhorn L; Srour EF; Harrington MA; Experimental hematology 1990 Jun
Role for cyclic AMP in the postreceptor control of cytokine-stimulated stromal cell growth factor production.
Derigs HG; Burgess GS; Klingberg D; Nahreini TS; Mochizuki DY; Williams DE; Boswell HS; Leukemia 1990 Jul
Derigs HG; Burgess GS; Klingberg D; Nahreini TS; Mochizuki DY; Williams DE; Boswell HS; Leukemia 1990 Jul
A novel mast cell growth factor (MCGF-3) produced by marrow-adherent cells that synergizes with interleukin 3 and interleukin 4.
Boswell HS; Mochizuki DY; Burgess GS; Gillis S; Walker EB; Anderson D; Williams DE; Experimental hematology 1990 Aug
Boswell HS; Mochizuki DY; Burgess GS; Gillis S; Walker EB; Anderson D; Williams DE; Experimental hematology 1990 Aug
A mutant RAS gene acts through protein kinase C to augment interleukin-3 dependent proliferation in a fastidious immortal myeloid cell line.
Boswell HS; Harrington MA; Burgess GS; Nahreini TL; Derigs HG; Hodges TD; English D; Crean CD; Gabig TG; Leukemia 1989 Sep
Boswell HS; Harrington MA; Burgess GS; Nahreini TL; Derigs HG; Hodges TD; English D; Crean CD; Gabig TG; Leukemia 1989 Sep
Effector function for RAS oncogene in interleukin-3-dependent myeloid cells involves diminished efficacy of prostaglandin E1-mediated inhibition of proliferation.
Derigs HG; Klingberg D; Tricot GJ; Boswell HS; Blood 1989 Nov 1
Derigs HG; Klingberg D; Tricot GJ; Boswell HS; Blood 1989 Nov 1
KRAS2 oncogene overexpression in myelodysplastic syndrome with translocation 5;12.
Srivastava A; Boswell HS; Heerema NA; Nahreini P; Lauer RC; Antony AC; Hoffman R; Tricot GJ; Cancer genetics and cytogenetics 1988 Oct 1
Srivastava A; Boswell HS; Heerema NA; Nahreini P; Lauer RC; Antony AC; Hoffman R; Tricot GJ; Cancer genetics and cytogenetics 1988 Oct 1
Restoration of adenylate cyclase responsiveness in murine myeloid leukemia permits inhibition of proliferation by hormone. Butyrate augments catalytic activity of adenylate cyclase.
Inhorn L; Fleming JW; Klingberg D; Gabig TG; Boswell HS; Blood 1988 Apr
Inhorn L; Fleming JW; Klingberg D; Gabig TG; Boswell HS; Blood 1988 Apr
Cellular control of in vitro progression of murine myeloid leukemia: progression accompanies acquisition of independence from growth factor and stromal cells.
Boswell HS; Srivastava A; Burgess JS; Nahreini P; Heerema N; Inhorn L; Padgett F; Walker EB; Geib RW; Leukemia 1987 Nov
Boswell HS; Srivastava A; Burgess JS; Nahreini P; Heerema N; Inhorn L; Padgett F; Walker EB; Geib RW; Leukemia 1987 Nov
A variant t(X;15)(p11;q22) translocation in acute promyelocytic leukemia.
Srivastava A; Heerema N; Lauer RC; Nahreini P; Boswell HS; Hoffman R; Antony AC; Cancer genetics and cytogenetics 1987 Nov
Srivastava A; Heerema N; Lauer RC; Nahreini P; Boswell HS; Hoffman R; Antony AC; Cancer genetics and cytogenetics 1987 Nov
Role of stromal populations in hemopoietic stem cell proliferation. I. Physically distinct subpopulations of hemopoietic stem cells and stromal progenitors determine long-term culture hemopoiesis.
Boswell HS; Albrecht PR; Shupe RE; Williams DE; Burgess J; Experimental hematology 1987 Jan
Boswell HS; Albrecht PR; Shupe RE; Williams DE; Burgess J; Experimental hematology 1987 Jan
The effects of purified recombinant murine interleukin-3 and/or purified natural murine CSF-1 in vivo on the proliferation of murine high- and low-proliferative potential colony-forming cells: demonstration of in vivo synergism.
Williams DE; Hangoc G; Cooper S; Boswell HS; Shadduck RK; Gillis S; Waheed A; Urdal D; Broxmeyer HE; Blood 1987 Aug
Williams DE; Hangoc G; Cooper S; Boswell HS; Shadduck RK; Gillis S; Waheed A; Urdal D; Broxmeyer HE; Blood 1987 Aug
The effects in vivo of purified preparations of murine macrophage colony stimulating factor-1, recombinant murine granulocyte-macrophage colony stimulating factor and natural and recombinant murine interleukin 3 without and with pretreatment of mice with purified iron-saturated human lactoferrin.
Broxmeyer HE; Williams DE; Boswell HS; Cooper S; Shadduck RK; Gillis S; Waheed A; Urdal DL; Immunobiology 1986 Sep
Broxmeyer HE; Williams DE; Boswell HS; Cooper S; Shadduck RK; Gillis S; Waheed A; Urdal DL; Immunobiology 1986 Sep
Pluripotential hematopoietic stem cells in post-5-fluorouracil murine bone marrow express the Thy-1 antigen.
Williams DE; Boswell HS; Floyd AD; Broxmeyer HE; Journal of immunology (Baltimore, Md. : 1950) 1985 Aug
Williams DE; Boswell HS; Floyd AD; Broxmeyer HE; Journal of immunology (Baltimore, Md. : 1950) 1985 Aug
Thy-1 antigen expression by murine high-proliferative capacity hematopoietic progenitor cells. I. Relation between sensitivity to depletion by Thy-1 antibody and stem cell generation potential.
Boswell HS; Wade PM Jr; Quesenberry PJ; Journal of immunology (Baltimore, Md. : 1950) 1984 Dec
Boswell HS; Wade PM Jr; Quesenberry PJ; Journal of immunology (Baltimore, Md. : 1950) 1984 Dec
Cryopreservation of marrow and stromal progenitor cells: use of long-term liquid culture as a measure of the recovery of renewable hematopoietic and stromal cells.
Boswell HS; Niskanen EO; Coppola MA; Quesenberry PJ; Experimental hematology 1983 Apr
Boswell HS; Niskanen EO; Coppola MA; Quesenberry PJ; Experimental hematology 1983 Apr
Role of accessory cells in B cell activation. IV. Ia+ accessory cells are required for the in vitro generation of thymic independent type 2 antibody responses to polysaccharide antigens.
Morrissey PJ; Boswell HS; Scher I; Singer A; Journal of immunology (Baltimore, Md. : 1950) 1981 Oct
Morrissey PJ; Boswell HS; Scher I; Singer A; Journal of immunology (Baltimore, Md. : 1950) 1981 Oct
Role of accessory cells in B cell activation. II. The interaction of B cells with accessory cells results in the exclusive activation of an Lyb5+ B cell subpopulation.
Boswell HS; Ahmed A; Scher I; Singer A; Journal of immunology (Baltimore, Md. : 1950) 1980 Sep
Boswell HS; Ahmed A; Scher I; Singer A; Journal of immunology (Baltimore, Md. : 1950) 1980 Sep
Role of accessory cells in B cell activation. III. Cellular analysis of primary immune response deficits in CBA/N mice: presence of an accessory cell-B cell interaction defect.
Boswell HS; Nerenberg MI; Scher I; Singer A; The Journal of experimental medicine 1980 Nov 1
Boswell HS; Nerenberg MI; Scher I; Singer A; The Journal of experimental medicine 1980 Nov 1
Role of accessory cells in B cell activation. I. Macrophage presentation of TNP-Ficoll: evidence for macrophage-B cell interaction.
Boswell HS; Sharrow SO; Singer A; Journal of immunology (Baltimore, Md. : 1950) 1980 Feb
Boswell HS; Sharrow SO; Singer A; Journal of immunology (Baltimore, Md. : 1950) 1980 Feb
Oncology
American Board of Internal Medicine - Internal Medicine
Leukemic and lymphoma care, myeloproliferative disorders
Org:
Desc: Trustee Teaching Award
Scope: University
Date: 2016-05-01
Desc: Trustee Teaching Award
Scope: University
Date: 2016-05-01
Looking for patient care?
To schedule an appointment with a faculty member physician of IU School of Medicine, contact Indiana University Health at 888-484-3258 or use the physician finder by clicking the button below.